BPBT
MACK

Boston Private Bank & Trust’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Boston Private Bank & Trust’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$812K Hold
8,689
– – 0.04% 246
2014
Q4 		$773K Buy
+8,689
New +$633K 0.04% 256

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Boston Private Bank & Trust's MACK Position: Q1 2015 in Review

Boston Private Bank & Trust held its Merrimack Pharmaceuticals, Inc. (MACK) position steady in Q1 2015 at 8,689 shares worth $812K. The position accounts for 0.04% of the portfolio, ranked #246.

Boston Private Bank & Trust first reported a position in MACK in Q4 2014 and has held it in 2 quarters since. 152 funds tracked by Wall St. Rank hold MACK as of Q1 2015.

  • Boston Private Bank & Trust held 8,689 shares of Merrimack Pharmaceuticals, Inc. worth $812K as of Q1 2015.
  • Boston Private Bank & Trust left its Merrimack Pharmaceuticals, Inc. share count unchanged in Q1 2015.
  • Merrimack Pharmaceuticals, Inc. made up 0.04% of Boston Private Bank & Trust's portfolio in Q1 2015, its #246 holding.
  • Boston Private Bank & Trust first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2014 and has held it in 2 quarters since.
  • 152 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.